| Tag | Content |
|---|
EnhancerAtlas ID | HS183-06574 |
Organism | Homo sapiens |
Tissue/cell | T47D-MTVL |
Coordinate | chr5:151047160-151049220 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr5:151047224-151047244 | CCCCCACCCACCCACATACC | + | 7.64 |
|
| | Number of super-enhancer constituents: 29 | ID | Coordinate | Tissue/cell |
| SE_00092 | chr5:151038273-151068423 | Adipose_Nuclei | | SE_01149 | chr5:151047922-151048820 | Adrenal_Gland | | SE_01149 | chr5:151048934-151050508 | Adrenal_Gland | | SE_01642 | chr5:151046499-151048829 | Aorta | | SE_01642 | chr5:151048841-151054644 | Aorta | | SE_02262 | chr5:151047880-151052993 | Astrocytes | | SE_06414 | chr5:151048505-151053374 | Brain_Hippocampus_Middle | | SE_36971 | chr5:151048304-151068162 | HSMMtube | | SE_38049 | chr5:151047800-151061350 | HUVEC | | SE_38890 | chr5:151048832-151052860 | IMR90 | | SE_41057 | chr5:151046533-151047686 | Left_Ventricle | | SE_41057 | chr5:151047795-151048904 | Left_Ventricle | | SE_41057 | chr5:151048909-151056082 | Left_Ventricle | | SE_42445 | chr5:151046699-151056123 | Lung | | SE_44210 | chr5:151047877-151052988 | NHDF-Ad | | SE_44814 | chr5:151046665-151047435 | NHLF | | SE_44814 | chr5:151048000-151048547 | NHLF | | SE_45698 | chr5:151046623-151047818 | Osteoblasts | | SE_45698 | chr5:151047857-151067767 | Osteoblasts | | SE_46698 | chr5:151047271-151047703 | Ovary | | SE_46698 | chr5:151047963-151048790 | Ovary | | SE_46698 | chr5:151048952-151049598 | Ovary | | SE_48812 | chr5:151046514-151047816 | Right_Atrium | | SE_48812 | chr5:151047943-151053155 | Right_Atrium | | SE_50590 | chr5:151048950-151053198 | Sigmoid_Colon | | SE_51537 | chr5:151048893-151053327 | Skeletal_Muscle | | SE_53114 | chr5:151048941-151053044 | Small_Intestine | | SE_53749 | chr5:151047881-151048734 | Spleen | | SE_53749 | chr5:151048885-151053712 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I151667 | chr5 | 151047272 | 151047703 |
|
Enhancer Sequence | TCTAGGTTCC AAACACAAGG GCGGTCAGCA CAGACCCTGC CTGGGCCGTG CTCCCCACCC 60
CAGGCCCCCA CCCACCCACA TACCACCTGC ATTGGTGGCC TTGGCACAGT GGCTCAACCT 120
CTCCAGGCCA CAGTTTCTTC ACAGGACAAT GAGCAGAGGA GATTATGTGT GGGAAGAATG 180
CCCTAGAAAT GCATTGTGCA AAGGCATGGC TGCTGCTTTC CTCAGCCTAA TCTGCTCTGC 240
TCAGGGAAAT GGATGGCTCC TGCACCTTAC TGGGTGCTGG GCTTTGGGTG TGATCCTAGC 300
TGAGACTGAG CCCATGTTGT TCACGTCAAC CACTGGCAGG TGTTTGAAGC TGGGAGGCTG 360
AGGGATCACA TCTATCCACA GGCCCAGCTT GGCAGGGAGT GGGGAGTAGA GGACTCAGGA 420
ATGTGTAACC ACCAGAACCT TCTTAGAAAT GATTCCAACC TGGTCTTTGG AACTTAGAAT 480
CCCAAATGTT GGACCTGAAG ATTTCATCCA AGTCCACACT TTTCTTTTCC TTTTCTTTTC 540
TTTTTTCTTT TTTTCTTCTT TTTTTTTTTT TTAGACAGGG TCTCACTCTG TTGCCCAGGC 600
TGGAGTGCAG TGGCACAATC ACGGCTCACT GCAGCCTCAG CCTCCTGGAC TCAACCAATC 660
CTCCCTCCTC AGCCTCCTGA GTAGCTGGGA CTACAGGCAC ATGCCACCAT ACCCAGCTAA 720
TTTTTGTATA TTTTCCAGAG ACAAGGTTTT GCCACGTTGC CCAGACTGGT CTCGAACTCC 780
TGAGCTCAAG TGATCCTCCC TACTCGGCCT CCCAAAGTGC TGGGATTACA GGCGTGAGCC 840
ACCGCGCCTG ACCCAGGTTC ACACTTTGTA CTGGACTTAT TAGAGGTCAG CATGGAGAGA 900
AGGGACTTGC TCAAGGCCAC AATGTCAGAG CCTCATCCAG CATCCAGGGC AGTGTGGTCA 960
CCTGGGGGCT TAGGGGTCTG TTCTTCCCTC ATCATTGAAC CAGGGAAAGT CCCCTCTGTG 1020
AGGCTACCTT CATCATCAGC TGGGGTCTGG GAGAGAATAT CTGGTGATAA AAACCTTAGG 1080
AGTTGAAGTG AGTGGGCAAC ATGCCTCAGG GAAAGCAAAG CCACTTCATA AAGACTCCTT 1140
AAGACAGGCT CTCTAGTCTT GCTGCCCAGG GACTTCCTAC CCATGCTTCT TCCCCCAACC 1200
CTCCTTTTCT ACTCTGTACC TTCTCAATTT CATACCTGGG GTCCCACGAG GAGAACTTTG 1260
TTTCCCACCC CCTACATACT TTTCTGCACC CTGTACACCT GAGGTAGGTG AGTGGCTCTC 1320
CTCATTGCCA TCGGGTGCCA GAATACACAA GACCCACAGT GTGGATGTTG CCTTGGAGGG 1380
GGAGCAGGTG TGGTCTTGGG GGTCTCCCAT GATAGGGAGG ATACTGAACA AGGCACTTGG 1440
CCCCACTGAG TTTGCAGCTG GGGTCACTAA CCAAAGATCA GACCACACCC TGGCATCCCT 1500
CCCCAGACAA CTGACTCCCA GGTTTCCAGA AGAGGGTGCT TATCCTCTCT CTTCGGAGGG 1560
CAGATAGGAA TGTAATGGAG TAAAAGGGTG AAGATATGAC AGTACCAAGT AACAGGGCCC 1620
AAAGCAAACC GACAGGCATG CCCTTATTTT AAAGCATTCA AAATCAGATA TTTTCAAAAT 1680
ATTTTGTAGG CCCAGGTCAA ACATCATTTT TGCTTTACAG TGTTGAAGCA AGAAAGATTC 1740
AACTTAGCCT GAGAGAAGAA ATTCTTCCTC ATTAGAGAAA TGAAATGCAG TTGTCTCAGA 1800
TGCTAGTGAG AGACTCCAGA AATCTTCCCT GATGTTGACC TTCCATAATC GCTCAGTCCT 1860
TCCCCAGAAA GTGCCCTGAA CTCAGAGTTG AGAGGAGCCA ACTCATAGAC AATTACCTCA 1920
TTTTATAAAT GGGGATGCCG AGACTCAGAA AGGGAGAGAG ATTTGCCCAA GATCACCCAG 1980
CATGGGGGTG GCAGAGACAG CATCAGTGCC AGCTCAGAGC TCTCTCCCCA AGACAGGAGT 2040
CTGGAAGGGC CCAAGGACAC 2060
|
